ARCHIVES

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

New Drug Combination Shrinks Kidney Cancers

June 30, 2006

Clearinghouse Finds Three Chemicals Pose Risk Of Cncer to Humans; 38 More Will Go On Test

August 5, 1977

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986

ACS Asks Higher NCI Authorization

March 24, 1978

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007